Navigation Links
eDataAudit Receives Approval from the American Board of Radiology
Date:7/14/2010

PITTSBURGH, July 14 /PRNewswire/ -- D3 Radiation Services announced today  that the American Board of Radiology (ABR) has qualified eDataAudit--a new service designed to reduce errors in the delivery of radiation therapy--as a Practice Quality Improvement (PQI) for the purpose of Maintenance of Certification (MOC).

With eDataAudit , participating clinics and radiation oncology physicists can order a comprehensive audit of their beam data through the use of a web portal: http://www.d3cdms.com. "This is a unique service that addresses a major recommendation of the American Association of Physicists in Medicine (AAPM) TG-106 report requiring beam data to be audited prior to going clinical," said Nabil Adnani, Ph.D., DABR, Chief Products Development Officer at D3 Radiation Services.

According to reports by international organizations such as the International Atomic Energy Authority and the World Health Organization, the majority of reported adverse events in radiation oncology can be traced back to errors committed during linear accelerator commissioning. More recently, the Radiological Physics Center (RPC) at M.D. Anderson Cancer Center published a report about the problems of credentialing radiation oncology clinics to participate in National Cancer Institute sponsored clinical trials. According to the center, approximately three out of 10 participating clinics failed their credentialing efforts, with the majority of the failures traceable to commissioning errors.

"With ABR's approval, eDataAudit will not only help minimize these errors but also provide reports that participating physicists can use to fulfill the 4th component of the ABR's Maintenance Of Certification requirements," Dr. Adnani noted.

Attendees of the 52nd AAPM Annual Meeting in Philadelphia on July 18th – 22 can learn more about eDataAudit by visiting D3's exhibit booth #731.

About D3 Radiation Services

D3 Radiation Services, based in Pittsburgh, offers a wide range of services that optimize the clinical application of advanced technologies in radiation oncology. D3 provides training, consultation on policies and protocols, remote treatment planning, and commissioning services to physicians, physicists, dosimetrists and therapists. Since 2001, D3 has assisted over 170 clinics with advanced radiotherapy and supported the treatment of over 17,000 patients.


'/>"/>
SOURCE D3 Radiation Services
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mylan Receives Approval for Nabumetone Tablets
2. Osseon Receives Patent Allowance for Novel Spinal VCF Treatment Devices
3. Orthocare Innovations Receives Prestigious R&D 100 Award for Novel Web-Based Rehabilitation Outcomes Assessment System
4. Exagen Diagnostics Receives Lab Accreditation From College of American Pathologists
5. Kiadis Pharma Receives IND Approval From FDA to Start Pivotal Clinical Trial With ATIR(TM) in the United States
6. K-V Pharmaceutical Company Receives Letter From New York Stock Exchange Regarding Delayed Filing of Its Annual Report on Form 10-K for Fiscal Year 2010
7. Nephros Receives Formal Response from FDA for 510(k) Application for Hemodiafiltration System
8. Watsons Generic Prograf® 5 mg Receives FDA Approval
9. Renhuang Pharmaceuticals Receives Approval to List on the NYSE Amex
10. Sangamo BioSciences Receives Michael J. Fox Foundation Funding to Develop Novel Drug for the Treatment of Parkinsons Disease
11. Biomerix Ventral Hernia Repair Mesh Receives FDA 510(k) Clearance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), ... cell disease and heart failure, today announced the pricing ... a price to the public of $0.275 per unit. ... common stock and one warrant to purchase one share ... of $0.42 per share. The warrants are exercisable six ...
(Date:2/10/2016)... Feb. 10, 2016  Silicon Biosystems Menarini Inc., ... that help uncover the biological complexities of disease ... a developer of innovative technologies for genomics research, ... aimed at enabling translational researchers to obtain high-quality ... hundred tumor and normal cells in an optimized ...
(Date:2/10/2016)... Feb. 9, 2016 CTI BioPharma Corp. ... an update regarding the clinical studies being conducted ... for pacritinib. Following the issuance of the Company,s ... clinical hold issued by the U.S. Food and ... Company received an oral communication from the FDA ...
Breaking Medicine Technology:
(Date:2/10/2016)... Angeles, CA (PRWEB) , ... February 10, 2016 ... ... Programming (NLP) practitioner, is known locally for a series of therapeutic sessions to ... in-the-moment in their characters and in their lives. The series, known as “Mindfulness ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... unveiling its revolutionary new 2.0 version at the International Roofing Expo in Orlando, ... power of the world's most advanced weather technology in the hands of consumers, ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... master charity program created to assist the local community. Pledging to select a ... and nonprofit organizations in the area. Their goal is to bring community awareness ...
(Date:2/10/2016)... ... ... Ongoing news of the ravages of traumatic brain injury (TBI) among former ... takes a closer look at cases of TBI being managed by their members. The ... the aging population, and identifies the challenges associated with their care. , During the ...
(Date:2/10/2016)... ... February 10, 2016 , ... Armune BioScience signed a ... network of laboratory service centers across the country. Launched in April of 2015, Apifiny ... detection of prostate cancer. Apifiny order volume exceeded 3,000 tests in 2015. Primary care ...
Breaking Medicine News(10 mins):